GAMMA Investing’s Mesa Laboratories MLAB Stock Holding History

GAMMA Investing’s Portfolio MLAB Stock Details MLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$28.5K	Buy	219 +21	+11%	+$2.38K	﹤0.01%	2725
2026 Q2	$19.7K	Hold	198	–	–	﹤0.01%	2842
2026 Q1	$17.5K	Buy	198 +180	+1,000%	+$15.5K	﹤0.01%	2782
2025 Q4	$1.41K	Sell	18 -19	-51%	-$1.45K	﹤0.01%	3701
2025 Q3	$2.48K	Sell	37 -129	-78%	-$9.29K	﹤0.01%	3396
2025 Q2	$15.6K	Buy	166 +14	+9%	+$1.54K	﹤0.01%	2589
2025 Q1	$18K	Buy	152 +31	+26%	+$4.22K	﹤0.01%	2443
2024 Q4	$16K	Sell	121 -2	-2%	-$246	﹤0.01%	2382
2024 Q3	$16K	Sell	123 -26	-17%	-$3.06K	﹤0.01%	2235
2024 Q2	$12.9K	Sell	149 -6	-4%	-$628	﹤0.01%	2101
2024 Q1	$17K	Sell	155 -20	-11%	-$2.02K	﹤0.01%	1755
2023 Q4	$16K	Buy	+175	New	+$17.1K	﹤0.01%	1639

Other funds holding MLAB

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

GWM

Gilpin Wealth Management Denver, Colorado $148M AUM 25.13% 1-Year Est. Return

GAMMA Investing's MLAB Position: Q3 2026 in Review

GAMMA Investing increased its Mesa Laboratories (MLAB) stake by 11% in Q3 2026, buying an estimated $2.38K and bringing the position to 219 shares worth $28.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2725.

GAMMA Investing first reported a position in MLAB in Q4 2023 and has held it in 12 quarters since. 4 funds tracked by Wall St. Rank hold MLAB as of Q3 2026.

GAMMA Investing held 219 shares of Mesa Laboratories worth $28.5K as of Q3 2026.
GAMMA Investing bought 21 Mesa Laboratories shares in Q3 2026, an estimated $2.38K.
Mesa Laboratories made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #2725 holding.
GAMMA Investing first reported a position in Mesa Laboratories in Q4 2023 and has held it in 12 quarters since.
4 funds tracked by Wall St. Rank held Mesa Laboratories as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.